Bombay High Court relief to Johnson & Johnson, company allowed to manufacture, sell baby powder Ruchika Sharma12 Jan 2023 1:42 PM IST“The executive cannot use a hammer to kill an ant. Is it always inevitable that when there is a single case of deviation or non-compliance (to...
Johnson and Johnson may eye deals that boost eye care, surgical robots businesses: CEO Joaquin Duato Ruchika Sharma10 Jan 2023 2:43 PM ISTDuato said many of its future deals would likely be small “tuck-in” acquisitions.
Johnson and Johnson consumer health unit Kenvue files for IPO Ruchika Sharma5 Jan 2023 12:15 PM ISTKenvue said J&J will continue to own at least 80.1% of the voting power of the company’s shares upon completion of the offering.
Abiomed now part of Johnson and Johnson Ruchika Sharma26 Dec 2022 2:15 PM ISTNew Brunswick: Johnson & Johnson has announced that the company has completed its acquisition of Abiomed, Inc. is now part of Johnson &...
CDSCO panel opines Johnson and Johnson to submit details of anticancer drug Teclistamab nod in EU, US Roshni Dhar16 Dec 2022 5:20 PM ISTIn response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and 90mg/vial, the...
Health Bulletin 16/December/2022 Dr. Nandita Mohan16 Dec 2022 4:40 PM ISTHere are the top health news for the day:NMC re-invites applications for establishment of new medical colleges, intake increase of MBBS, PG medical...
After Sanofi drops out of Horizon bid, Amgen emerges as frontrunner Ruchika Sharma12 Dec 2022 1:30 PM ISTSanofi said on Sunday that it was no longer in discussions with Horizon and does not intend to make an offer for it.
Janssen seeks USFDA nod for Multiple myeloma treatment Talquetamab Ruchika Sharma11 Dec 2022 1:00 PM ISTRaritan, N.J.: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Biologics License Application...
Sanofi, JnJ, Amgen in talks to acquire Horizon Therapeutics Ruchika Sharma1 Dec 2022 4:33 PM ISTBengaluru: Horizon Therapeutics Plc said on Tuesday its board was engaged in highly preliminary discussions with three pharmaceutical giants for...
Patent infringement: Johnson and Johnson sues Amgen over plan to sell drug similar to Stelara Ruchika Sharma1 Dec 2022 1:15 PM ISTIf Amgen launches its drug, J&J said it would infringe J&J's patent on the drug's active ingredient and on its use for treating ulcerative colitis.
Re-examine JnJ baby powder samples: HC directs Maharashtra govt Ruchika Sharma15 Nov 2022 1:30 PM IST"Let them be allowed to manufacture, we will not permit them any handover for sale or even distribution,” the court said.
Johnson and Johnson to acquire Abiomed for USD 16.6 billion to boost cardiovascular business Ruchika Sharma2 Nov 2022 12:30 PM ISTNew Brunswick: Johnson & Johnson and Abiomed have entered into a definitive agreement under which Johnson & Johnson will acquire through a...
